查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786532

周邊藥物釋放型球囊市場：全球產業分析、規模、佔有率、成長、趨勢及預測（2025-2032）

Peripheral Drug Eluting Balloon Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 273 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球周邊藥物釋放型球囊市場的綜合研究報告，本報告全面評估了重要市場動態，包括市場促進因素、趨勢、挑戰，並對市場結構提供了詳細的見解。

關鍵見解

  • 周邊藥物釋放型球囊市場規模（2025年）：10.352億美元
  • 市場預測（2032年）：18.443億美元
  • 全球市場成長率（2025-2032年年複合成長率）：8.6%

周邊藥物釋放型球囊市場 - 範圍

周邊藥物釋放型球囊（DEB）是一種用於治療周邊動脈疾病（PAD）的醫療設備，透過在血管成形術中將抗血管再阻塞藥物直接輸送至動脈壁。 DEB 結合了球囊血管成形術的機械優勢和藥物輸送的藥理優勢，降低了血管再阻塞的發生率，並無需永久性植入。此市場服務於醫院、門診手術中心和導管室，主要用於治療股膕動脈和膝下動脈病變。全球 PAD 負擔的日益加重、球囊設計和藥物塗層技術的進步以及對微創治療的日益偏好，推動市場擴張。

市場促進因素：

全球周邊藥物釋放型球囊市場受多種關鍵因素驅動，包括人口老化導致周邊動脈疾病盛行率上升，以及糖尿病和吸菸率上升。藥物塗層技術（例如基於紫杉醇和Sirolimus的製劑）的進步顯著改善了臨床療效，推動了其在醫療保健領域的應用。對微創且經濟高效的支架替代方案的需求日益成長，也推動了市場成長。此外，已開發國家優惠的償付政策以及人們對周邊動脈疾病（PAD）及其治療方案日益成長的認知，進一步推動了新興國家對置入術球囊（DEB）的需求。

市場限制：

儘管市場成長潛力巨大，產品核可仍面臨嚴格的監管要求，尤其是在藥物塗層的安全性和有效性方面。近期關於紫杉醇塗層器械及其長期安全性的爭議引發了臨床醫生和監管機構的擔憂，影響了其採用率。此外，這些器械的高昂成本以及開發中地區償付額度的有限性限制了其廣泛應用。此外，裸球囊和支架等替代治療方法的存在也加劇了市場競爭壓力。

市場機會

周邊藥物釋放型球囊市場蘊含著巨大的機會，這得益於塗層技術的創新、新興市場的拓展以及與影像和導航技術的整合，改善了治療效果。開發具有更優藥物釋放特性和更高生物相容性的下一代DEB球囊將抓住新的需求。臨床試驗投資的增加以及與研究機構的合作預計將提供可靠的資料，以支持更廣泛的臨床應用。此外，亞太和拉丁美洲醫療基礎設施的成長將為市場滲透和成長開闢新的途徑。

本報告探討的關鍵問題

  • 推動全球周邊藥物釋放型球囊市場成長的主要因素有哪些？
  • 哪些藥物類型和解剖用途影響產品的開發和採用？
  • 法律規範和安全問題如何影響市場趨勢和臨床使用？
  • 周邊DEBs市場的主要企業是誰？他們採取什麼策略來加強其競爭地位？
  • 每個地區的新興趨勢和長期成長前景如何？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 價值鏈分析
  • 宏觀經濟因素
    • 世界GDP展望
    • 全球建設產業概況
    • 全球採礦業概況
  • 預測因子 - 相關性和影響力
  • COVID-19影響評估
  • PESTLE分析
  • 波特五力分析
  • 地緣政治緊張局勢：市場影響
  • 監管和技術格局

第3章 市場動態

  • 促進因素
  • 抑制因素
  • 機會
  • 趨勢

第4章 2019-2032年價格趨勢分析

  • 區域價格分析
  • 依細分市場定價
  • 價格影響因素

第5章 全球周邊藥物釋放型球囊市場展望：實績（2019-2024年）與預測（2025-2032年）

  • 主要亮點
  • 全球周邊藥物釋放型球囊市場展望：藥物塗層
    • 簡介/主要調查結果
    • 2019-2024年市場規模趨勢分析：依藥物塗層
    • 2025-2032年市場規模預測：依藥物塗層
      • 紫杉醇藥物塗層
      • Sirolimus藥物塗層
    • 市場吸引力分析：藥物塗層
  • 全球周邊藥物釋放型球囊市場展望：適應症
    • 簡介/主要調查結果
    • 2019-2024年市場規模趨勢分析：依適應症
    • 2025-2032年當前市場規模預測：依適應症
      • 周邊動脈疾病
      • 周邊動脈瘤
      • 支架內血管再阻塞
    • 市場吸引力分析：跡象
  • 全球周邊藥物釋放型球囊市場展望：動脈類型
    • 簡介/主要調查結果
    • 2019-2024年市場規模趨勢：依動脈類型
    • 2025-2032年當前市場規模預測：依動脈類型
      • 頸動脈
      • Fem-Pop動脈
      • 髂動脈
      • Infrapop動脈
    • 市場吸引力分析：動脈類型
  • 全球周邊藥物釋放型球囊市場展望：最終用戶
    • 簡介/主要調查結果
    • 2019-2024年市場規模趨勢分析：依最終用戶
    • 2025-2032年當前市場規模預測：依最終用戶
      • 醫院
      • 門診手術中心/門診病人
      • 心導管實驗室
    • 市場吸引力分析：最終用戶

第6章 全球周邊藥物釋放型球囊市場展望：依地區

  • 主要亮點
  • 2019-2024年市場規模趨勢分析：依地區
  • 2025-2032年目前市場規模預測：依地區
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：地區

第7章 北美周邊藥物釋放型球囊市場展望：實績（2019-2024年）與預測（2025-2032年）

第8章 歐洲周邊藥物釋放型球囊市場展望：實績（2019-2024年）與預測（2025-2032年）

第9章 東亞周邊藥物釋放型球囊市場展望：實績（2019-2024年）和預測（2025-2032年）

第10章 南亞和大洋洲外周藥物釋放型球囊市場展望：實績（2019-2024年）和預測（2025-2032年）

第11章 拉丁美洲周邊藥物釋放型球囊市場展望：實績（2019-2024年）和預測（2025-2032年）

第12章 中東和非洲周邊藥物釋放型球囊市場展望：實績（2019-2024年）和預測（2025-2032年）

第13章 競爭格局

  • 2025年市場佔有率分析
  • 市場結構
    • 競爭強度圖
    • 競爭儀表板
  • 公司簡介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Cook Medical Inc.
    • MicroPort Scientific Corporation（Endovastec（TM））
    • Medtronic Plc.
    • Cardinal Health, Inc.
    • B. Braun Melsungen AG
    • BIOTRONIK SE &Co. KG
    • Becton, Dickinson and Company
    • WL Gore &Associates Inc.
    • Getinge AB
    • Terumo Corp
    • Kyoto Medical Planning Co Ltd
    • iVascular SLU
    • AMG International GmbH

第14章 附錄

  • 調查方法
  • 調查前提
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP27211

Persistence Market Research has recently released a comprehensive report on the worldwide market for peripheral drug eluting balloons. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Peripheral Drug Eluting Balloons Market Size (2025E): USD 1035.2 Million
  • Projected Market Value (2032F): USD 1,844.3 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.6%

Peripheral Drug Eluting Balloons Market - Report Scope:

Peripheral drug eluting balloons (DEBs) are medical devices used to treat peripheral arterial disease (PAD) by delivering anti-restenotic drugs directly to the arterial walls during angioplasty. These devices combine the mechanical benefits of balloon angioplasty with the pharmacological advantages of drug delivery, reducing the incidence of restenosis and eliminating the need for permanent implants. The market serves hospitals, ambulatory surgical centers, and catheterization labs, with applications primarily in the treatment of femoropopliteal and below-the-knee arterial lesions. Market expansion is driven by the increasing global burden of PAD, technological improvements in balloon design and drug coatings, and growing preference for minimally invasive procedures.

Market Growth Drivers:

The global peripheral drug eluting balloons market is propelled by several key factors, including the rising prevalence of peripheral arterial disease due to aging populations and increasing incidences of diabetes and smoking. Advancements in drug coating technologies, such as paclitaxel and sirolimus-based formulations, have significantly improved clinical outcomes, supporting adoption across healthcare settings. The growing demand for minimally invasive and cost-effective alternatives to stenting also boosts market growth. Additionally, favorable reimbursement policies in developed countries and a rise in awareness about PAD and its treatment options further fuel demand for DEBs.

Market Restraints:

Despite strong growth potential, the market faces challenges including stringent regulatory requirements for product approvals, particularly concerning the safety and efficacy of drug coatings. Recent controversies over paclitaxel-coated devices and their long-term safety have raised concerns among clinicians and regulatory bodies, impacting adoption rates. Moreover, high device costs and limited reimbursement in developing regions restrict widespread use. The presence of alternative treatment modalities, such as bare balloons and stents, also poses competitive pressure on the market.

Market Opportunities:

The peripheral drug eluting balloons market presents significant opportunities driven by innovation in coating technologies, expansion into emerging markets, and integration with imaging and navigation technologies for enhanced procedural outcomes. Development of next-generation DEBs with improved drug release profiles and biocompatible materials can capture new demand. Increasing investment in clinical trials and collaboration with research institutions are expected to generate robust data supporting broader clinical use. Moreover, growing healthcare infrastructure in Asia-Pacific and Latin America opens new avenues for market penetration and growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the peripheral drug eluting balloons market globally?
  • Which drug types and anatomical applications are influencing product development and adoption?
  • How are regulatory frameworks and safety concerns shaping market trends and clinical usage?
  • Who are the leading companies in the peripheral DEBs market, and what strategies are they employing to strengthen their competitive positioning?
  • What are the emerging trends and long-term growth prospects across different regions?

Competitive Intelligence and Business Strategy:

These companies are investing in the development of new drug formulations, biodegradable coatings, and balloons with improved deliverability and precision. Collaborations with academic institutions and clinical centers enable real-world validation and product optimization. Expansion into emerging markets through distribution agreements and regulatory approvals plays a critical role in capturing untapped demand and diversifying revenue streams.

Key Companies Profiled:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec(TM))
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Becton, Dickinson and Company
  • W. L. Gore & Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular S.L.U
  • AMG International GmbH
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Koninklijke Philips N.V.
  • REVA Medical

Peripheral Drug Eluting Balloons Market Research Segmentation:

Drug Coating:

  • Paclitaxel Drug Coating
  • Sirolimus drug Coating
  • Others

Indication:

  • Peripheral Arterial Disease
  • Peripheral Aneurysms
  • In-Stent Restenosis
  • Others

Artery Type:

  • Carotid Arteries
  • Fem-Pop Arteries
  • Iliac Arteries
  • Infrapop Arteries

End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients
  • Cardiac Catheterization Labs

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Peripheral Drug Eluting Balloons Market Snapshot 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global Construction Industry Overview
    • 2.3.3. Global Mining Industry Overview
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 5.1. Key Highlights
  • 5.2. Global Peripheral Drug Eluting Balloons Market Outlook: Drug Coating
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Mn) Analysis by Drug Coating, 2019-2024
    • 5.2.3. Current Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
      • 5.2.3.1. Paclitaxel Drug Coating
      • 5.2.3.2. Sirolimus drug Coating
    • 5.2.4. Market Attractiveness Analysis: Drug Coating
  • 5.3. Global Peripheral Drug Eluting Balloons Market Outlook: Indication
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) Forecast, by Indication, 2025-2032
      • 5.3.3.1. Peripheral Arterial Disease
      • 5.3.3.2. Peripheral Aneurysms
      • 5.3.3.3. In-Stent Restenosis
    • 5.3.4. Market Attractiveness Analysis: Indication
  • 5.4. Global Peripheral Drug Eluting Balloons Market Outlook: Artery Type
    • 5.4.1. Introduction/Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis by Artery Type, 2019-2024
    • 5.4.3. Current Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
      • 5.4.3.1. Carotid Arteries
      • 5.4.3.2. Fem-Pop Arteries
      • 5.4.3.3. Iliac Arteries
      • 5.4.3.4. Infrapop Arteries
    • 5.4.4. Market Attractiveness Analysis: Artery Type
  • 5.5. Global Peripheral Drug Eluting Balloons Market Outlook: End User
    • 5.5.1. Introduction/Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2024
    • 5.5.3. Current Market Size (US$ Mn) Forecast, by End User, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Ambulatory Surgical Centers/Outpatients
      • 5.5.3.3. Cardiac Catheterization Labs
    • 5.5.4. Market Attractiveness Analysis: End User

6. Global Peripheral Drug Eluting Balloons Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 7.4.1. Paclitaxel Drug Coating
    • 7.4.2. Sirolimus drug Coating
  • 7.5. North America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 7.5.1. Peripheral Arterial Disease
    • 7.5.2. Peripheral Aneurysms
    • 7.5.3. In-Stent Restenosis
  • 7.6. North America Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 7.6.1. Carotid Arteries
    • 7.6.2. Fem-Pop Arteries
    • 7.6.3. Iliac Arteries
    • 7.6.4. Infrapop Arteries
  • 7.7. North America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 7.7.1. Hospitals
    • 7.7.2. Ambulatory Surgical Centers/Outpatients
    • 7.7.3. Cardiac Catheterization Labs

8. Europe Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 8.4.1. Paclitaxel Drug Coating
    • 8.4.2. Sirolimus drug Coating
  • 8.5. Europe Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 8.5.1. Peripheral Arterial Disease
    • 8.5.2. Peripheral Aneurysms
    • 8.5.3. In-Stent Restenosis
  • 8.6. Europe Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 8.6.1. Carotid Arteries
    • 8.6.2. Fem-Pop Arteries
    • 8.6.3. Iliac Arteries
    • 8.6.4. Infrapop Arteries
  • 8.7. Europe Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 8.7.1. Hospitals
    • 8.7.2. Ambulatory Surgical Centers/Outpatients
    • 8.7.3. Cardiac Catheterization Labs

9. East Asia Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 9.4.1. Paclitaxel Drug Coating
    • 9.4.2. Sirolimus drug Coating
  • 9.5. East Asia Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 9.5.1. Peripheral Arterial Disease
    • 9.5.2. Peripheral Aneurysms
    • 9.5.3. In-Stent Restenosis
  • 9.6. East Asia Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 9.6.1. Carotid Arteries
    • 9.6.2. Fem-Pop Arteries
    • 9.6.3. Iliac Arteries
    • 9.6.4. Infrapop Arteries
  • 9.7. East Asia Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 9.7.1. Hospitals
    • 9.7.2. Ambulatory Surgical Centers/Outpatients
    • 9.7.3. Cardiac Catheterization Labs

10. South Asia & Oceania Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 10.4.1. Paclitaxel Drug Coating
    • 10.4.2. Sirolimus drug Coating
  • 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 10.5.1. Peripheral Arterial Disease
    • 10.5.2. Peripheral Aneurysms
    • 10.5.3. In-Stent Restenosis
  • 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 10.6.1. Carotid Arteries
    • 10.6.2. Fem-Pop Arteries
    • 10.6.3. Iliac Arteries
    • 10.6.4. Infrapop Arteries
  • 10.7. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 10.7.1. Hospitals
    • 10.7.2. Ambulatory Surgical Centers/Outpatients
    • 10.7.3. Cardiac Catheterization Labs

11. Latin America Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 11.4.1. Paclitaxel Drug Coating
    • 11.4.2. Sirolimus drug Coating
  • 11.5. Latin America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 11.5.1. Peripheral Arterial Disease
    • 11.5.2. Peripheral Aneurysms
    • 11.5.3. In-Stent Restenosis
  • 11.6. Latin America Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 11.6.1. Carotid Arteries
    • 11.6.2. Fem-Pop Arteries
    • 11.6.3. Iliac Arteries
    • 11.6.4. Infrapop Arteries
  • 11.7. Latin America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 11.7.1. Hospitals
    • 11.7.2. Ambulatory Surgical Centers/Outpatients
    • 11.7.3. Cardiac Catheterization Labs

12. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 12.4.1. Paclitaxel Drug Coating
    • 12.4.2. Sirolimus drug Coating
  • 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 12.5.1. Peripheral Arterial Disease
    • 12.5.2. Peripheral Aneurysms
    • 12.5.3. In-Stent Restenosis
  • 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 12.6.1. Carotid Arteries
    • 12.6.2. Fem-Pop Arteries
    • 12.6.3. Iliac Arteries
    • 12.6.4. Infrapop Arteries
  • 12.7. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 12.7.1. Hospitals
    • 12.7.2. Ambulatory Surgical Centers/Outpatients
    • 12.7.3. Cardiac Catheterization Labs

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. Abbott Laboratories
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Boston Scientific Corporation
    • 13.3.3. Cook Medical Inc.
    • 13.3.4. MicroPort Scientific Corporation (Endovastec(TM))
    • 13.3.5. Medtronic Plc.
    • 13.3.6. Cardinal Health, Inc.
    • 13.3.7. B. Braun Melsungen AG
    • 13.3.8. BIOTRONIK SE & Co. KG
    • 13.3.9. Becton, Dickinson and Company
    • 13.3.10. W. L. Gore & Associates Inc.
    • 13.3.11. Getinge AB
    • 13.3.12. Terumo Corp
    • 13.3.13. Kyoto Medical Planning Co Ltd
    • 13.3.14. iVascular S.L.U
    • 13.3.15. AMG International GmbH

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations